Soumya Chakravarty

All papers authored by Soumya Chakravarty

This paper was not found in any repository, but could be made available legally by the author.

This paper is made freely available by the publisher.

2023 Philip J. Mease

, Alexis Ogdie

, John Tesser

, Natalie J. Shiff

, Iris Lin

, Soumya D. Chakravarty

, Michael Kelleman

, Rhiannon Dodge, Robert R. McLean

, Aaron Broadwell

, Arthur Kavanaugh

, Joseph F. Merola

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Download from doi.org

2022 John Tesser

, Iris Lin

, Natalie J. Shiff

, Soumya D. Chakravarty

, Gabriela Schmajuk

, Nevin Hammam

, Sheetal Desai

Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

M. Elaine Husni

, Atul Deodhar

, Sergio Schwartzman

, Soumya D. Chakravarty

, Elizabeth C. Hsia, Jocelyn H. Leu, Yiying Zhou, Kim H. Lo, Arthur Kavanaugh

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

Upload

Christopher T. Ritchlin

, Philip J. Mease

, Wolf-Henning Boehncke, John Tesser, Elena Schiopu

, Soumya D. Chakravarty

, Alexa P. Kollmeier, Xie L. Xu, May Shawi, Yusang Jiang, Shihong Sheng, Yanli Wang, Stephen Xu, Joseph F. Merola, Iain B. McInnes

and 1 other authors

Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies

Download from doi.org

Philip J. Mease

, Soumya D. Chakravarty

, Robert R. McLean, Taylor Blachley, Toana Kawashima, Iris Lin, Arthur Kavanaugh, Alexis Ogdie

Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen‐B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Upload

Iain B. McInnes

, Proton Rahman, Alice B. Gottlieb, Elizabeth C. Hsia, Alexa P. Kollmeier, Xie L. Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D. Chakravarty

, Désirée van der Heijde, Philip J. Mease

Long‐Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through Two Years: Results From a Phase III , Randomized, Double‐Blind , Placebo‐Controlled Study Conducted in Biologic‐Naive Patients With Active Psoriatic Arthritis

Upload

2021 Philip J. Mease

, Iain B. McInnes, Lai-Shan Tam

, Kiefer Eaton

, Steve Peterson, Agata Schubert, Soumya D. Chakravarty

, Anna Parackal, Chetan S. Karyekar, Sandhya Nair, Wolf-Henning Boehncke, Christopher Ritchlin

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis

Upload

Iain B. McInnes

, Proton Rahman, Alice B. Gottlieb

, Elizabeth C. Hsia, Alexa P. Kollmeier, Soumya D. Chakravarty

, Xie L. Xu, Ramanand A. Subramanian, Prasheen Agarwal, Shihong Sheng, Yusang Jiang, Bei Zhou, Yanli Zhuang, Désirée Heijde, Philip J. Mease

Efficacy and Safety of Guselkumab, an Interleukin‐23p19–Specific Monoclonal Antibody, Through One Year in Biologic‐Naive Patients With Psoriatic Arthritis

Upload

Alexis Ogdie

, Jessica A. Walsh, Soumya D. Chakravarty

, Steven Peterson, Kim Hung Lo, Lilianne Kim, Nan Li, Elizabeth C. Hsia, Eric K. H. Chan, Arthur Kavanaugh, M. Elaine Husni

The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial

Upload

Christopher T. Ritchlin

, Philip S. Helliwell

, Wolf-Henning Boehncke, Enrique R. Soriano

, Elizabeth C. Hsia, Alexa P. Kollmeier, Soumya D. Chakravarty

, Federico Zazzetti, Ramanand A. Subramanian, Xie L. Xu, Qing C. Zuraw, Shihong Sheng, Yusang Jiang, Prasheen Agarwal, Bei Zhou and 4 other authors

Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced

Download from doi.org

2020 Philip Mease

, M. Elaine Husni

, Soumya D. Chakravarty

, Shelly Kafka, Dennis Parenti, Lilianne Kim, Kim Hung Lo, Elizabeth C. Hsia, Arthur Kavanaugh

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Soumya Chakravarty